Literature DB >> 11318790

Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin.

K Lewandowski1, H S Randeva, C J O'Callaghan, R Horn, G F Medley, E W Hillhouse, G Brabant, P O'Hare.   

Abstract

OBJECTIVE: Insulin and glucocorticoids are known to increase total leptin levels. However, the effects of insulin and glucocorticoids on the components of the leptin system - free leptin (FL), bound leptin (BL) and soluble leptin receptor (SR) - have not been elucidated. The aim of this study was to determine if there is a differential effect of insulin and glucocorticoids on the leptin system.
MATERIAL AND METHODS: In the first of two studies (study 1), we measured free leptin (FL), bound leptin (BL), a soluble leptin receptor (SR) and insulin, by specific RIA methods, in six healthy subjects on a control day, and subsequently during a hyperinsulinaemic euglycaemic clamp study. In the second study (study 2) we measured the same parameters in six healthy subjects, before (day 1) and during administration of dexamethasone over 3 consecutive days.
RESULTS: In study 1, on the control day FL levels rose over the 16 h monitoring period (P = 0.057) and SR levels declined (P < 0.001), but there was no change of BL levels. Even after accounting for diurnal variation, FL levels increased even more substantially over 12 h of insulin infusion than observed on the control day (P < 0.001). In study 2, mean FL concentration doubled from day 1 to day 2 (P = 0.01) and remained elevated subsequently. In contrast to FL, BL and SR levels remained unchanged during the study. Fasting insulin levels (pmol/l) increased from day 1 to day 2, but this rise only approached significance on day 4 (P = 0.05).
CONCLUSION: We conclude that insulin and dexamethasone increase free leptin levels, but do not change the concentrations of bound leptin and soluble leptin receptor. Furthermore, the dexamethasone-induced rise in leptin levels is (at least partially) independent of the effects of glucocorticoid-induced hyperinsulinaemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318790     DOI: 10.1046/j.1365-2265.2001.01243.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Influence of cortisol status on leptin secretion.

Authors:  A Leal-Cerro; A Soto; M A Martínez; C Dieguez; F F Casanueva
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

2.  Plasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia.

Authors:  Eric D Bruder; Lauren Jacobson; Hershel Raff
Journal:  J Endocrinol       Date:  2005-06       Impact factor: 4.286

3.  The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients.

Authors:  Rodrigo Bueno de Oliveira; Sophie Liabeuf; Hirokazu Okazaki; Aurelie Lenglet; Lucie Desjardins; Horst-Dieter Lemke; Raymond Vanholder; Gabriel Choukroun; Ziad A Massy
Journal:  Clin Kidney J       Date:  2012-01-01

4.  Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin.

Authors:  Bee K Tan; Raghu Adya; Xiaoye Shan; Farhatullah Syed; Krzysztof C Lewandowski; John P O'Hare; Harpal S Randeva
Journal:  Diabetes Care       Date:  2008-10-13       Impact factor: 19.112

5.  Insulin and metformin regulate circulating and adipose tissue chemerin.

Authors:  Bee K Tan; Jing Chen; Syed Farhatullah; Raghu Adya; Jaspreet Kaur; Dennis Heutling; Krzysztof C Lewandowski; J Paul O'Hare; Hendrik Lehnert; Harpal S Randeva
Journal:  Diabetes       Date:  2009-06-05       Impact factor: 9.461

6.  Leptin, soluble leptin receptor, and transforming growth factor-beta1 levels in minimal change nephrotic syndrome.

Authors:  Necla Buyan; Ozan Ozkaya; Aysun Bideci; Oğuz Söylemezoğlu; Peyami Cinaz; Sevim Gönen; Süleyman Kalman; Sevcan Bakkaloğlu; Enver Hasanoğlu
Journal:  Pediatr Nephrol       Date:  2003-07-29       Impact factor: 3.714

7.  Prevalence of thyroid nodules and their associated clinical parameters: a large-scale, multicenter-based health checkup study.

Authors:  Jae Hoon Moon; Min Kyung Hyun; Ja Youn Lee; Jung Im Shim; Tae Hyuk Kim; Hoon Sung Choi; Hwa Young Ahn; Kyung Won Kim; Do Joon Park; Young Joo Park; Ka Hee Yi
Journal:  Korean J Intern Med       Date:  2017-07-07       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.